ArticleLife science alliance2022
Artemisinin-independent inhibitory activity of
Open access · goldAbstract read
In one paragraph
Article in Life science alliance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 21 citations in OpenAlex.
- Perceptions and Acceptability ofHealthcare (Basel, Switzerland) · 2026Article
- Article
- Assessment of the in vitro activity and selectivity of Artemisia afra and Artemisia annua aqueous extracts against artemisinin-resistant Plasmodium falciparum.Malaria journal · 2025Article
- Exploring the Phytochemical Diversity and Anti-Plasmodial Potential ofMolecules (Basel, Switzerland) · 2025Article
- Medicinal plants as more sustainable therapeutic solutions:Global health economics and sustainability · 2025Article
- The Antiviral and Antimalarial Prodrug Artemisinin from theCurrent issues in molecular biology · 2024Review
- Transfection Models to InvestigatePathogens (Basel, Switzerland) · 2023Review
- Artemisinin as a therapeuticNatural product reports · 2023Review
- A versatile Plasmodium falciparum reporter line expressing NanoLuc enables highly sensitive multi-stage drug assays.Communications biology · 2023Article
- Knowledge about Asymptomatic Malaria and Acceptability of UsingInternational journal of environmental research and public health · 2023Article
- Expression of the Fab enzymes (Fab I and Fab Z) fromJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2023Article
- Anti-Frontiers in microbiology · 2023Article
- In vitro models for human malaria: targeting the liver stage.Trends in parasitology · 2022Review
- Antimalarial Activity of Methoxylated Flavonoid Fraction (Cirsimaritin-Dominated) fromIranian journal of pharmaceutical research : IJPRArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 6 institutions in 3 countries.
Kutub AshrafSorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National pour la Recherche Scientifique (CNRS), Centre d'Immunologie et des Maladies Infectieuses, CIMI, Paris, France.ORCID 0000-0003-2527-0085
Shahin TajeriSorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National pour la Recherche Scientifique (CNRS), Centre d'Immunologie et des Maladies Infectieuses, CIMI, Paris, France.ORCID 0000-0002-0482-1194
Christophe-Sébastien ArnoldApicoLipid Team, Institute for Advanced Biosciences, Centre National pour la Recherche Scientifique (CNRS) UMR5309, Université Grenoble Alpes, Institut National de la Santé et de la Recherche Médicale (INSERM) U1209, La Tronche, France.ORCID 0000-0002-2392-5837
Nadia AmanzougagheneSorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National pour la Recherche Scientifique (CNRS), Centre d'Immunologie et des Maladies Infectieuses, CIMI, Paris, France.
Jean-François FranetichSorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National pour la Recherche Scientifique (CNRS), Centre d'Immunologie et des Maladies Infectieuses, CIMI, Paris, France.
Amélie VantauxUnité d'Epidémiologie Moléculaire du Paludisme, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.ORCID 0000-0002-7945-961X
Valérie SoulardSorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National pour la Recherche Scientifique (CNRS), Centre d'Immunologie et des Maladies Infectieuses, CIMI, Paris, France.
Mallaury BordessoullesSorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National pour la Recherche Scientifique (CNRS), Centre d'Immunologie et des Maladies Infectieuses, CIMI, Paris, France.
Guillaume CazalsInstitut des Biomolécules Max Mousseron, UMR 5247, Université de Montpellier, Montpellier, France.
Teun BousemaDepartment of Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands.
Geert-Jan van GemertDepartment of Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands.ORCID 0000-0002-2740-5337
Roger Le GrandCommissariat à l'Energie Atomique et aux Energies Alternatives (CEA)-Université Paris Sud 11-INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases (IMVA-HB), Infectious Disease Models and Innovative Therapies (IDMIT) Department, Institut de Biologie François Jacob (IBFJ), Direction de la Recherche Fondamentale (DRF), Fontenay-aux-Roses, France.
Nathalie Dereuddre-BosquetCommissariat à l'Energie Atomique et aux Energies Alternatives (CEA)-Université Paris Sud 11-INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases (IMVA-HB), Infectious Disease Models and Innovative Therapies (IDMIT) Department, Institut de Biologie François Jacob (IBFJ), Direction de la Recherche Fondamentale (DRF), Fontenay-aux-Roses, France.
Jean-Christophe BaraleInstitut Pasteur, Pasteur International Network, Malaria Translational Research Pasteur International Unit, Phnom Penh, Cambodia and Paris, Paris, France.ORCID 0000-0002-1203-0376
Benoit WitkowskiUnité d'Epidémiologie Moléculaire du Paludisme, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Georges SnounouCommissariat à l'Energie Atomique et aux Energies Alternatives (CEA)-Université Paris Sud 11-INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases (IMVA-HB), Infectious Disease Models and Innovative Therapies (IDMIT) Department, Institut de Biologie François Jacob (IBFJ), Direction de la Recherche Fondamentale (DRF), Fontenay-aux-Roses, France.
Romain DuvalUniversité de Paris, Institut de Recherche pour le Développement (IRD), UMR 261 MERIT, Paris, France romain.duval@ird.fr.
Cyrille Y BottéApicoLipid Team, Institute for Advanced Biosciences, Centre National pour la Recherche Scientifique (CNRS) UMR5309, Université Grenoble Alpes, Institut National de la Santé et de la Recherche Médicale (INSERM) U1209, La Tronche, France romain.duval@ird.fr.ORCID 0000-0002-2245-536X
Dominique MazierSorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National pour la Recherche Scientifique (CNRS), Centre d'Immunologie et des Maladies Infectieuses, CIMI, Paris, France dominique.mazier@sorbonne-universite.fr.
Centre National de la Recherche Scientifique · FRUniversité Paris-Sud · FRInstitut Pasteur · FRRadboud University Nijmegen · NLUniversité de Montpellier · FRUniversité Paris Cité · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artemisinin-based combination therapies (ACT) are the frontline treatments against malaria worldwide. Recently the use of traditional infusions from
Indexed as
AntimalarialsArtemisiaArtemisininsErythrocytesHepatocytesHumansLife Cycle StagesMalariaParasitic Sensitivity TestsPlant ExtractsPlasmodiumAntimalarialsArtemisininsPlant Extracts
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.